Grupo Fleury
Alessandro Ferreira serves as the Diretor Executivo Comercial e Marketing at Grupo Fleury since April 2023. Prior to this role, Alessandro held various positions at Grupo Hermes Pardini from October 1998 to April 2023, including Presidente do Conselho de Administração da Toxicologia Pardini, Vice-Presidente Comercial e Marketing, and Diretor Comercial Corporativo, overseeing the commercial and marketing strategies, as well as research and development initiatives. Alessandro's earlier roles within the organization involved responsibilities in commercial support, logistics, and process integration. Education includes a Ph.D. in Molecular Genetics and an MBA in Marketing and Economics from Universidade Federal de Minas Gerais and Ibmec, respectively, along with additional governance training from Board Academy Br.
This person is not in any teams
This person is not in any offices
Grupo Fleury
1 followers
With almost 100 years, Grupo Fleury is one of the most respected medical and health organizations in Brazil, recognized by the community and public opinion for its technical, medical, service and management excellence. In recent years, it has accelerated its growth towards being an integrated, preventive and hybrid health ecosystem, combining physical and digital offers. With this integrated system, it has increasingly been able to support the physician's clinical conduct in the search for solutions that meet the needs of each patient, while contributing to the sustainability of the system. In addition to diagnostic medicine, it has expanded its activities to the stages of prevention, primary, secondary and tertiary care. With more than 13 thousand employees and 3 thousand doctors, the company is present in the markets of São Paulo, Rio de Janeiro, Rio Grande do Sul, Paraná, Bahia, Pernambuco, Rio Grande do Norte, Maranhão, Espírito Santo and Distrito Federal. The company has established itself as one of the biggest references in best social, economic and environmental practices (Environmental, Social and Governance - ESG). Recently, it was recognized and was included for the second time in the 'Dow Jones Sustainability Index (DJSI)', of the New York Stock Exchange, in the DJSI Emerging Markets portfolio, being the only company in the Health sector in the Americas to be part of of the index.